CAS 1622075-09-5

Clivatuzumab

CAS : 1622075-09-5

Clivatuzumab

Degré de pureté : ≥98%

Ref: 54-BUP20117

Clivatuzumab

CAS : 1622075-09-5

Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good

Degré de pureté : SDS-PAGE:95% SEC-HPLC:99.99%

Couleur et forme : Liquid

Masse moléculaire : 145.42 kDa

Ref: TM-T77191